The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADMA BIOLOGICS INC | COM | 000899104 | 576 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 2,678 | 232,864 | SH | SOLE | 232,864 | 0 | 0 | ||
APOLLO ENDOSURGERY INC | COM | 03767D108 | 4,472 | 739,165 | SH | SOLE | 739,165 | 0 | 0 | ||
BERKELEY LTS INC | COM | 084310101 | 2,840 | 399,402 | SH | SOLE | 399,402 | 0 | 0 | ||
CVRX INC | COM | 126638105 | 3,236 | 540,273 | SH | SOLE | 540,273 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 1,244 | 7,898 | SH | SOLE | 7,898 | 0 | 0 | ||
NEURONETICS INC | COM | 64131A105 | 2,897 | 955,999 | SH | SOLE | 955,999 | 0 | 0 | ||
RENALYTIX PLC | ADS | 75973T101 | 3,179 | 459,461 | SH | SOLE | 459,461 | 0 | 0 | ||
SERA PROGNOSTICS INC | CLASS A COM | 81749D107 | 3,521 | 929,073 | SH | SOLE | 929,073 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 2,265 | 607,269 | SH | SOLE | 607,269 | 0 | 0 | ||
THE ONCOLOGY INSTITUTE INC | COM | 68236X100 | 3,167 | 444,244 | SH | SOLE | 444,244 | 0 | 0 | ||
VAPOTHERM INC | COM | 922107107 | 18,461 | 1,328,109 | SH | SOLE | 1,328,109 | 0 | 0 |